ANN ARBOR, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics Inc. (NASDAQ: ESPR) has announced the granting of 73,500 restricted stock units (RSUs) to 12 new employees under the company's 2017 Inducement Equity Incentive Plan. This plan is specifically designed for individuals who are newly employed by Esperion or have had a bona fide period of non-employment. According to the terms, each RSU will vest 25 percent on the one-year anniversary of the recipient's vesting commencement date, with the remaining 75 percent vesting in twelve equal quarterly installments thereafter, contingent upon continued employment with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esperion Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9508190-en) on August 07, 2025, and is solely responsible for the information contained therein.